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Аннотация. Были получены данные о термической стабильности 4-метилфенил-О-β-Д-глюкопиранозид. 
Данная субстанция обладает диуретическим эффектом сравнимым с современными диуретиками. 
Исследование термической стабильности проводили методом ТГ-ДСК-МС в инертной атмосфере 
аргона, в интервале температур 25‒600 С°. Из полученных дериватограмм можно сделать вывод, что 
термическая стабильность субстанции соизмерима с термической стабильностью современных 
диуретиков. Был предположен механизм термического разложения субстанции и выявлены химические 
маркеры данного процесса.  
 
Introduction. Nowadays diuretics take important place in clinical practice for various diseases treatment. 
Diuretics is a group of pharmaceutical products used for excretion of water and salts from an organism[1].  
Diuretics are ordered not only for chronic disease treatment, but also in emergency conditions for a patient. In 
addition, most of diuretics enter into the composition of complex medication for comorbidities treatment [2]. 
However, all diuretics have many side effects including a fatal outcome [3]. 
Russian scientists took out a patent 4-methylphenyl-O-β-D-glucopyranoside, which possesses diuretic 
activity and does not increase daily excretion of natrium and potassium ions. This compound differs significantly 
from modern diuretics. It is worth noting that the thermochemical properties of the compound have not been 
studied, and the thermal stability is the most important parameter when developing the technology for producing 
solid dosage forms. Thus, the aim of our research is to investigate the thermal stability of the 4-methylphenyl-O-
β-D-glucopyranoside substance (Fig.1). 
Materials and methods. Glycoside has been obtained from the corresponding tetraacetate. Deacetylation 
was perfomed by the Zempman method using sodium methoxide in methanol [4]. Acetate glycoside was 
obtained by fusion of α-glucose petaacetate with the corresponding aluminum phenolates. 
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Fig. 1. Constitutional formula of 4-methylphenyl-O-β-D-glucopyranoside 
 
Investigation of thermal stability was conducted using TG-DSC-MS on SDT Q600 V20.9 Build 20 
synchronous analyzer. The analysis was performed in the temperature range of 25‒600 С° under an inert argon 




Fig. 2. TG-DSC and MID result of 4-methylphenyl-O-β-D-glucopyranoside 
 
Experimental part. TG-DSC method provides defining the change in the sample mass and registers the 
effects of thermal processes at the same time. Also the tandem system of thermogravimetric equipment with 
mass detector allows us to determine simultaneously molecular ions of gaseous products. This allows us not only 
to determine the qualitative composition of the gaseous products, but also to know the temperate of the thermal 
decomposition of the substance. 
It is shown in the thermograms that the decomposition process goes in one stage. It is obvious from the 
compound thermogram (Fig.2) that in the temperature range of 25‒100°С the variability of mass indicating the 
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absence of crystal water is observed. The decomposition process starts immediately after melting the sample at 
177°С (Tmelt=178°С [5]). The decomposition process goes in one stage in the temperature range of 230‒330°С. 
It should be said that the process is registered in the gaseous phase p-cresol (Mr=108 g/mol) and acetic aldehyde 
(Mr=44 g/mol). This fact indicates the simultaneous decomposition of the glycoside to the corresponding p-
cresol and levoglucosan. Simultaneously p-cresol exhale with decomposition of the glycoside (Tr=201°С[6]) and 
levoglucosan at this temperature rapidly decomposes to form acetaldehyde (Mr=44 g/mol). Because of this fact 
the glycoside has rather high decomposition temperature of all of these processes are very intensely and 
simultaneously, does not allow dividing them into graphs. 
Conclusion.  
• The thermal stability of the compounds was studied by thermogravimetric analysis and differential scanning 
calorimetry, equipped with a mass detector (DSC-TG-MS). From the obtained date we can draw a 
conclusion, that the substance is heat-proof to a temperature of 177°C. Compound decomposition 
temperature is quite comparable to the decomposition temperature of modern diuretics: furosemide (Tdec = 
200 ° C), amiloride (Tdec = 135 ° C) and spiranolacton (Tdec = 200 ° C [7]) indicating a sufficient stability of 
the studied substances to pharmaceutical products. 
• Summarizing data will help develop an optimal process scheme for producing pharmaceutical shape. Also 
dates allow the development of methods for quality control and authenticity of the substance of TG method 
[8]. Assumptions mechanism of thermal decomposition can help ascertain chemicals markers, which allows 
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